Skip to content

Using Virtual Reality (VR) Technology in Gynecological and Obstetrics Procedures

Using Virtual Reality (VR) Technology in Gynecological Procedures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05941390
Acronym
VR
Enrollment
270
Registered
2023-07-12
Start date
2023-09-01
Completion date
2024-09-01
Last updated
2023-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain, Virtual Reality

Brief summary

A randomized control trial will be conducted in Assuta Ashdod hospital, in the department of obstetrics and gynecology. Pregnant and non pregnant women, undergoing one of the procedures (external cephalic version,amniocentesis or hysteroscopy), will be approached. All willing patients meeting the criteria will sign an informed consent form will. After signing informed consent patients will be randomly allocated into three groups:1) control (no use of VR). 2) use of VR googles without positive psychology. 3) use of VR googles with positive psychology. Before and after the procedure each group will answer pain and anxiety questionnaires. In addition, following, following each procedure, salivary cortisol levels will be measured.

Interventions

DEVICEVR without positive psychology

Using VR goggles showing relaxing short videos without sound

DEVICEVR with positive psychology

Using VR goggles showing relaxing short videos with positive psychological messages

Sponsors

Assuta Ashdod Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* ECV- single tone, breech presentation,gestional age 35-40,unknown drug allergy * amniocintesis -single tone,gestional age 16-24 week, * hysteroscopy-women age 18-60 , diagnostic procedure,

Exclusion criteria

* ECV-previous cesarian section, contruction,low known plt count ,premature rupture of membrane * amniocintesis- Known fetal malformations, amnionitis * hysteroscopy-pregnancy, PID

Design outcomes

Primary

MeasureTime frameDescription
stress cortisol saliva levelup to 5 minutes after the procedureeach arm after the procedure will be mesured stress cortisol level in saliva

Secondary

MeasureTime frameDescription
pain levelsup to 5 minutes aftereach arm after the procedure will fill pain questioner. pain questioners using visual analog score. 0- to 10, while 0 is no pain at all, 10 is the worse pain ever felt.the patients will fill the questioner before and after the procedures.
anxiety levelsup to 5 minutes aftereach arm after the procedure will fill anxiety questioner. anxiety questioner using the short depression , anxiety and stress scale (DASS-21). the patients will fill the questioners before and after the procedures.

Contacts

Primary ContactNoa glick fishman, MD
noagl@assuta.co.il0544443952

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026